The survival period of chronic glomerulonephritis after active and standardized treatment is generally between several years and decades, and the rate of disease progression varies greatly among individuals, and the specific survival time is closely related to the type and severity of renal pathology, whether to take effective measures to slow down the progression of renal function, whether the treatment is appropriate, and whether to avoid various risk factors. Chronic glomerulonephritis can be seen in a variety of renal pathologies, such as thylakoid proliferative glomerulonephritis, focal segmental glomerulosclerosis, etc., all of which can progress to glomerulosclerosis of varying degrees, with tubular atrophy and interstitial fibrosis in the corresponding renal units. If the disease is mild in thylakoid proliferative glomerulonephritis, some patients can survive for decades, and even some patients can be the same as normal people; if it is focal segmental glomerulosclerosis and the disease is serious, the patient’s survival time is generally between a few years, and it will even be quickly progressed to uremia. If effective measures are taken to slow down the progression of renal function, appropriate treatment is provided, and risk factors are actively avoided, the prognosis of patients with chronic glomerulonephritis is better, and their survival time will be longer, up to several decades; on the contrary, the survival time is shorter, and death can be caused by renal failure within a few years. When chronic glomerulonephritis progresses to uremia, life can be prolonged by hemodialysis treatment; if necessary, kidney transplantation is also feasible. It is recommended that patients with chronic glomerulonephritis should consult a doctor in time, and follow the doctor’s instructions to actively standardize the treatment, so as to avoid delaying the condition.